R. Woolas

发表

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

D. Oram, M. Parmar, I. Jacobs, 2016, The Lancet.

Screening for ovarian cancer: a pilot randomised controlled trial

Steven J Skates, Nicola MacDonald, Usha Menon, 1999, The Lancet.

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Matthew Burnell, Steven J Skates, Tim Mould, 2009, Journal of Family Planning and Reproductive Health Care.

Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature.

R. Woolas, K. Dhar, N. Das, 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Implementation of a Robotic Surgical Program in Gynaecological Oncology and Comparison with Prior Laparoscopic Series

R. Woolas, N. Povolotskaya, D. Brinkmann, 2015, International journal of surgical oncology.

Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer

R. Woolas, N. Das, N. Povolotskaya, 2014, Surgery research and practice.

Mixed serous—endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma

R. Woolas, I. Hammond, A. McCartney, 1993, International Journal of Gynecologic Cancer.

The diagnosis of endometrial atypia by hysteroscopy with guided biopsy in postmenopausal patients with hyperplasia: a reliable practice?

R. Woolas, S. Rahimi, C. Marani, 2016, Gynecological Surgery.

Recruitment to multicentre trials lessons from

Lesley, Leeson, M. Parmar, 2008 .

UKCTOCS: descriptive study Recruitment to multicentre trialslessons from

M. Parmar, I. Jacobs, U. Menon, 2008 .

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar

I. Jacobs, U. Menon, A. Ryan, 2020, Trials.

Elevated serum levels of macrophage colony-stimulating factor and OVX1, 11 months prior to the diagnosis of stage IC ovarian cancer

R. Bast, I. Jacobs, R. Woolas, 1996 .

Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS

M. Parmar, I. Jacobs, U. Menon, 2021, BJOG : an international journal of obstetrics and gynaecology.

Fallopian tube carcinoma: an under-recognized primary neoplasm

R. Woolas, J. Smith, F. Sharp, 1997 .

Changes in the management of vulval cancer.

R. Woolas, K. Dhar, 2003, Best practice & research. Clinical obstetrics & gynaecology.

Endometrial cancer before age 35 and subsequent use of hormone replacement therapy

R. Woolas, I. Hammond, A. McCartney, 1993 .

Lymphatic mapping and sentinel node biopsy in early vulvar cancer

R. Woolas, K. Dhar, 2005, BJOG : an international journal of obstetrics and gynaecology.

Gastrostomy tubes in patients with recurrent gynaecological cancer and intestinal obstruction

M. Gore, R. Woolas, J. Shepherd, 1999, British journal of obstetrics and gynaecology.

Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.

R. Woolas, K. Dhar, T. Needhirajan, 2005, Gynecologic oncology.

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome

R. Woolas, M. Seckl, E. Newlands, 1998, British journal of obstetrics and gynaecology.

Investigation of women with endometrial carcinoma using serum vascular endothelial growth factor (VEGF) measurement

R. Woolas, R. Gornall, E. Coombes, 2000, International Journal of Gynecologic Cancer.

Large Loop Diathermy of the Transformation Zone: Is ‘See and Treat’ An Acceptable Option for the Management of Women with Abnormal Cervical Smears?

R. Woolas, C. Brown, D. Oram, 1994 .

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses.

M R Conaway, A. Berchuck, I. Jacobs, 1995, Gynecologic oncology.

Elevation of multiple serum markers in patients with stage I ovarian cancer.

R. Bast, A. Berchuck, I. Jacobs, 1993, Journal of the National Cancer Institute.

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

M. Parmar, I. Jacobs, U. Menon, 2021, The Lancet.

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Steven J Skates, Yinhua Yu, R. Bast, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Matthew Burnell, Martin Widschwendter, Tim Mould, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study

I. Jacobs, R. Woolas, S. Skates, 1996, BMJ.

What is the true incidence of primary fallopian tube carcinoma?

J. Grudzinskas, I. Jacobs, R. Woolas, 1993, International Journal of Gynecologic Cancer.

Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.

Matthew Burnell, Steven J Skates, Tim Mould, 2011, The Lancet. Oncology.

Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports

R. Woolas, D. Oram, A. Davies, 1991, British journal of obstetrics and gynaecology.

Streptococcus milleri infection mimicking ovarian carcinoma

R. Woolas, A. Senapati, N. Cripps, 1999, British journal of obstetrics and gynaecology.

The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index

D. Oram, I. Jacobs, R. Woolas, 1993 .

Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience.

R. Reznek, I. Jacobs, R. Woolas, 1999, Radiology.

Cytological Follow-up of Women Older than 50 Years With High-Grade Cervical Smear Treated by Large Loop Excision

R. Woolas, N. Das, J. Bevan, 2009, Journal of lower genital tract disease.

Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2020, Gynecologic oncology.

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.

Daniel W Chan, Yinhua Yu, R. Bast, 2007, Gynecologic oncology.

Soluble interleukin‐2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer

G. Mills, R. Bast, A. Berchuck, 1995, Cancer.

UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis

I. Jacobs, U. Menon, A. Ryan, 2020, Trials.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, I. Jacobs, U. Menon, 2008, BMJ : British Medical Journal.

Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2021, Cancers.

Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2017, BMJ Open.

Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

M. Parmar, I. Jacobs, U. Menon, 2011, Trials.

Cancer of the Endometrium

R. Woolas, Ellen Bull, 2013 .

The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index.

D. Oram, I. Jacobs, R. Woolas, 1994, British journal of obstetrics and gynaecology.

SCREENING FOR OVARIAN CANCER : A PILOT RANDOMISED CONTROLLED TRIAL

Ian J. Jacobs, Nicola MacDonald, Usha Menon, 1999 .

Risk of significant gynaecological pathology in women with ?glandular neoplasia on cervical cytology

R. Woolas, J. Bevan, D. Brinkmann, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma

R. Woolas, R. Gornall, P. Hogston, 2002, BJOG : an international journal of obstetrics and gynaecology.

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

M. Parmar, I. Jacobs, U. Menon, 2017, British Journal of Cancer.

Ovarian cancer identified through screening with serum markers but not by pelvic imaging.

R. Bast, I. Jacobs, R. Woolas, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.

R. Bast, Z. Zhang, S. Barnhill, 1999, Gynecologic oncology.

Vaginal intra-epithelial neoplasia in Rokitansky-Kuster-Hauser syndrome: Case report

R. Woolas, I. Hammond, K. Williams, 1993 .

Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.

R. Woolas, A. McCartney, K. Williams, 1994, Gynecologic Oncology.

The cost effectiveness of screening for ovarian cancer : results from the UK Collaborative Trial of Ovarian Cancer Screening ( UKCTOCS )

A. Ryan, M. Burnell, N. Amso, 2019 .

Experience in the Management of Patients Older Than 80 Years With Vulval Cancer

R. Woolas, G. Khoury, Y. Nagar, 2009, International Journal of Gynecologic Cancer.

Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.

R. Bast, R. Woolas, 1993, BMJ.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, U. Menon, A. Ryan, 2008, British medical journal.

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)

D. Oram, I. Jacobs, M. Parmar, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening

I. Jacobs, U. Menon, A. Gentry-Maharaj, 2010, British Journal of Cancer.

Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

M. Parmar, U. Menon, A. Gentry-Maharaj, 2008, BMJ : British Medical Journal.